Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Cytokinetics Inc
NASDAQ:CYTK
Cytokinetics Inc
NASDAQ:CYTK
Price:
63.295
USD
-0.02%
Market Closed
Market Cap:
$8.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cytokinetics Inc
NASDAQ:CYTK
|
US |
|
Atomic Eagle Ltd
ASX:AEU
|
AU |
|
Lifestyle Communities Ltd
ASX:LIC
|
AU |
|
U
|
United Therapeutics Corp
F:UTH
|
US |
|
H
|
Hantop Inc
KOSDAQ:002680
|
KR |
|
Komatsu Ltd
F:KOMA
|
JP |
|
I
|
Industrial and Commercial Bank of China Ltd
DUS:ICK
|
CN |
|
S
|
Societe Anonyme des Bains de Mer et du Cercle des Etrangers a Monaco SA
XMUN:RJ8
|
MC |
|
G
|
Grand Canal Land PCL
SET:GLAND
|
TH |
|
C
|
China Rare Earth Holdings Ltd
XMUN:RAE
|
CN |
|
China Pacific Insurance Group Co Ltd
SSE:601601
|
CN |
|
XBiotech Inc
NASDAQ:XBIT
|
US |
|
Atlantic Lithium Ltd
LSE:ALL
|
AU |
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
Percheron Therapeutics Ltd
ASX:PER
|
AU |
|
L
|
Laramide Resources Ltd
F:L4R
|
CA |
|
WhiteHorse Finance Inc
NASDAQ:WHF
|
US |
|
R
|
Relx PLC
F:RDED
|
UK |
|
Astra Agro Lestari Tbk PT
IDX:AALI
|
ID |
|
Physicians Realty Trust
NYSE:DOC
|
US |
|
R
|
Relx PLC
NYSE:RELX
|
UK |
|
Cuscal Ltd
F:Y49
|
AU |
|
C
|
Charles Schwab Corp
DUS:SWG
|
US |
|
E
|
Endesa SA
XMUN:ENA
|
ES |
Wall St Price Targets
CYTK Price Forecast
Based on 22 analysts
Based on 22 analysts
+72% Upside
from
$63.295
today
Cytokinetics Inc (CYTK)’s 12-month stock price forecast through October 2027 has a consensus target of $109.14, implying 72% upside. The forecast is based on price targets from 22 Wall Street analysts.
CYTK Analyst Rating
Based on 23 analysts
Based on 23 analysts
Analysts rate CYTK Strong buy, with 21 of 23 recommending Buy or Strong buy.
Cytokinetics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CYTK's stock price target?
Price Target
109.14
USD
109.14
USD
According to Wall Street analysts, the average 1-year price target for CYTK is 109.14 USD with a low forecast of 81.81 USD and a high forecast of 153.3 USD.
What is the Revenue forecast for Cytokinetics Inc?
Projected CAGR
65%
65%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 8 years is 65%.